BidaskClub upgraded shares of RTI Surgical (NASDAQ:RTIX) from a strong sell rating to a sell rating in a research note released on Saturday.
Separately, Zacks Investment Research raised shares of RTI Surgical from a sell rating to a hold rating in a research report on Friday, October 13th.
Shares of RTI Surgical (NASDAQ:RTIX) traded up $0.15 during trading on Friday, reaching $4.45. 415,034 shares of the company were exchanged, compared to its average volume of 177,712. The company has a current ratio of 3.34, a quick ratio of 1.21 and a debt-to-equity ratio of 0.25. RTI Surgical has a 12-month low of $3.01 and a 12-month high of $6.00. The stock has a market cap of $264.82, a PE ratio of -63.57, a price-to-earnings-growth ratio of 1.98 and a beta of 1.76.
RTI Surgical (NASDAQ:RTIX) last announced its quarterly earnings results on Thursday, November 2nd. The medical equipment provider reported $0.01 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.01. RTI Surgical had a net margin of 1.01% and a return on equity of 2.29%. The firm had revenue of $66.69 million during the quarter, compared to analysts’ expectations of $65.63 million. RTI Surgical’s revenue for the quarter was up .2% on a year-over-year basis. analysts predict that RTI Surgical will post 0.05 earnings per share for the current year.
Large investors have recently bought and sold shares of the business. Citigroup Inc. boosted its position in RTI Surgical by 2,850.1% in the 2nd quarter. Citigroup Inc. now owns 21,152 shares of the medical equipment provider’s stock valued at $124,000 after buying an additional 20,435 shares during the last quarter. Prudential Financial Inc. purchased a new position in RTI Surgical in the 3rd quarter valued at about $111,000. Thompson Davis & CO. Inc. boosted its position in RTI Surgical by 138.8% in the 2nd quarter. Thompson Davis & CO. Inc. now owns 25,077 shares of the medical equipment provider’s stock valued at $147,000 after buying an additional 14,577 shares during the last quarter. Citadel Advisors LLC boosted its position in RTI Surgical by 85.7% in the 3rd quarter. Citadel Advisors LLC now owns 26,786 shares of the medical equipment provider’s stock valued at $122,000 after buying an additional 12,361 shares during the last quarter. Finally, Brandywine Global Investment Management LLC purchased a new position in RTI Surgical in the 2nd quarter valued at about $183,000. 69.90% of the stock is owned by institutional investors.
COPYRIGHT VIOLATION WARNING: This news story was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The correct version of this news story can be read at https://www.dispatchtribunal.com/2018/01/08/rti-surgical-rtix-upgraded-at-bidaskclub.html.
RTI Surgical Company Profile
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.